Cellectricon, a leading provider of cell-based screening solutions for research and drug discovery, today announced its collaboration with University of Lódz, Poland. Under the agreement University of Lódz invests in Cellaxess®HT, the worlds first system for high throughput transfection enabling reagent-free delivery of any genetic material to cells.To view Multimedia News Release, go to http://www.prnewswire.com/mnr/cellectricon/39261/
Genre: Entertainment
by: comments
